TMLI Plus Chemotherapy in High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Clinical trial NCT06598969 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06598969
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Myeloid Leukemia, Acute

Start date: 2024-12-30
Primary completion: 2026-12-30
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.